OverviewChartNewsTraderScreen

UC DIS.CERT. 12/24 CALL AMG/  DE000HC7KRY6  /

gettex
5/9/2024  9:47:00 PM Chg.+0.0300 Bid9:59:18 PM Ask9:59:18 PM Underlying Strike price Expiration date Option type
2.0900EUR +1.46% 2.0800
Bid Size: 20,000		 2.0900
Ask Size: 20,000		 Amgen Inc 220.00 USD 12/18/2024 Call
GlobeNewswire 5/9 Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/9 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 5/9 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 5/8 US closes flat to higher with more earnings on the horizon
GlobeNewswire 5/8 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 5/3 US closes higher after softer-than-expected jobs print
TeleTrader 5/3 Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 5/3 Amgen soars 14% on positive weight-loss drug data
TeleTrader 5/2 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 5/2 US surges at close as traders weigh Fed remarks
TeleTrader 5/2 US opens higher, Dow jumps 240 points
GlobeNewswire 5/2 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 5/2 US higher premarket after Fed's decision
GlobeNewswire 5/1 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 4/30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 4/24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 4/24 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 4/16 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 4/15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer